Announcement
29 Oct 2018
In October 2018, the European Investment Bank (EIB) signed a loan agreement with Newron Pharmaceuticals S.p.A. to mainly support its development programmes in central nervous system diseases. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
29 Oct 2018
Revocation date:
No revocation date
Updated: 29 Oct 2018
State loan
In force
The loan agreement between the European Investment Bank (EIB) and Newron Pharmaceuticals S.p.A. was signed on 29 October 2018 and has a total value of EUR 40 million (approx. USD 45....
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.